sprite-preloader
Anzeige
Mehr »
Freitag, 15.12.2017 Börsentäglich über 12.000 News von 575 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen
13.10.2017 | 18:31
(3 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

DUBLIN, October 13, 2017 /PRNewswire/ --

The "Global Veterinary Anti-infectives Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The Global Veterinary Anti-infectives Market is poised to grow at a CAGR of around 8.9% over the next decade to reach approximately $10.4 billion by 2025

Some of the prominent trends that the market is witnessing include increasing infectious disease in animals, growing concerns about animal meat quality, and rising health awareness of pet animal.

Based on drug class the market is categorized into antifungal agents, antiparasitic agents, antiviral agents, antimicrobial agents, and other drug class. Further, antimicrobial agents separated into cephalosporins, macrolides, penicillin's, quinolones, tetracyclines, and others.

By disease the market is segmented by florfenicol, beta-lactams, aminosidine, oxytetracycline, marbofloxacin, and freeze-dried ceftiofur.

Depending on the species the market is classified into farm animal, companion animals. Further, farm animal segmented by cattle, fish, swine, sheep, and poultry. Companion animals diversified into cats, dogs, and horses.

On basis of mode of administration the market is segmented by topical, parenteral, and oral. Based on distribution channel the market is categorized into veterinary clinics, pharmacies, veterinary hospitals, and other distribution channels.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies for the existing players, new entrants and the future investors.

Key Topics Covered:

1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing infectious disease in animals
3.1.2 Growing concerns about animal meat quality
3.1.3 Rising health awareness of pet animal
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness

4 Veterinary Anti-infectives Market, By Drug Class
4.1 Antifungal Agents
4.2 Antiparasitic Agents
4.3 Antiviral Agents
4.4 Antimicrobial Agents
4.4.1.1 Cephalosporins
4.4.1.2 Macrolides
4.4.1.3 Penicillins
4.4.1.4 Quinolones
4.4.1.5 Tetracyclines
4.4.1.6 Others
4.5 Other Drug Class

5 Veterinary Anti-infectives Market, By Disease
5.1 Florfenicol
5.2 Beta-lactams
5.3 Aminosidine
5.4 Oxytetracycline
5.5 Marbofloxacin
5.6 Freeze-dried ceftiofur

6 Veterinary Anti-Infectives Market, By Species
6.1 Farm animal
6.1.1.1 Cattle
6.1.1.2 Fish
6.1.1.3 Swine
6.1.1.4 Sheep
6.1.1.5 Poultry
6.2 Companion Animals
6.2.1.1 Cats
6.2.1.2 Dogs
6.2.1.3 Horses

7 Veterinary Anti-infectives Market, By Mode of Administration
7.1 Topical
7.2 Parenteral
7.3 Oral

8 Veterinary Anti-infectives Market, By Distribution Channel
8.1 Veterinary Clinics
8.2 Pharmacies
8.3 Veterinary Hospitals
8.4 Other Distribution Channels

9 Veterinary Anti-infectives Market, By Geography

10 Key Player Activities
10.1 Mergers & Acquisitions
10.2 Partnerships, Joint Venture's, Collaborations and Agreements
10.3 Product Launch & Expansions
10.4 Other Activities

11 Leading Companies

  • Bayer AG
  • Cipla Limited
  • Dechra Pharmaceuticals PLC
  • Eli Lilly and Company (Elanco Animal Health)
  • Heska Corp (Diamond Animal Health)
  • Merck & Co., Inc. (Merck Animal Health)
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Sanofi (Merial Animal Health)
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis, Inc.
  • Boehringer Ingelheim GmbH
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Limited
  • Norbrook Laboratories Limited
  • Zydus Animal Health Limited

For more information about this report visit https://www.researchandmarkets.com/research/7t6wst/global_veterinary

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


© 2017 PR Newswire